cannabis indica

Índice completo — página 18 de 77

Estudos 1.701 a 1.800 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2021. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 1.701 a 1.800

  1. 2021

    Associations among marijuana use, health-related quality of life, exercise, depression and sleep in cancer survivors

    DesfavorávelMetanáliseDepressão
  2. 2021

    Associations between adolescent cannabis use and young-adult functioning in three longitudinal twin studies

    DesfavorávelMetanáliseEfeitos Adversos da CannabisDisfunção Cognitiva
  3. 2021

    Associations Between Prenatal Cannabis Exposure and Childhood Outcomes: Results From the ABCD Study

    DesfavorávelMetanáliseGestação
  4. 2021

    Associations of Serum Fatty Acid Proportions with Obesity, Insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study

  5. 2021

    At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk

  6. 2021

    Attenuation of Oxidative Stress and Inflammatory Response by Chronic Cannabidiol Administration Is Associated with Improved n-6/n-3 PUFA Ratio in the White and Red Skeletal Muscle in a Rat Model of High-Fat Diet-Induced Obesity

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoObesidade+2
  7. 2021

    Attitudes towards and use of cannabis in New Zealand patients with inflammatory bowel disease: an exploratory study

    FavorávelMetanáliseDII — Doença Inflamatória Intestinal
  8. 2021

    Attitudes, beliefs, and changing trends of cannabidiol (CBD) oil use among caregivers of individuals with Alzheimer's disease

    FavorávelMetanáliseDoença de Alzheimer
  9. 2021

    Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeDepressãoDisfunção CognitivaAyahuasca
  10. 2021

    Be under your own influence: Effectiveness of a Culturally-Adapted drug prevention campaign targeting Reservation-Dwelling American Indian youth

  11. 2021

    Behavioral and pharmacological effects of cannabidiol (CBD) and the CBD analogue KLS-13019 in mouse models of pain and reinforcement

  12. 2021

    Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder

    FavorávelEstudo em AnimaisAutismoTetraidrocanabinol (THC)Endocanabinoide (não especificado)+2
  13. 2021

    Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists

  14. 2021

    Beneficial Effects of Cannabis on Blood-Brain Barrier Function in Human Immunodeficiency Virus

    FavorávelEnsaio ClínicoInflamaçãoHIV/AIDSTraumatismo Cranioencefálico
  15. 2021

    Benign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial

    DesfavorávelMetanálise ClínicaEfeitos Adversos da CannabisHIV/AIDS
  16. 2021

    Beta-Caryophyllene Exhibits Anti-Proliferative Effects through Apoptosis Induction and Cell Cycle Modulation in Multiple Myeloma Cells

    FavorávelEstudo LaboratorialCâncer — MielomaCanabinoides Sintéticos AM-x
  17. 2021

    Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Cocaína
  18. 2021

    Beta-Caryophyllene, a CB2R Selective Agonist, Protects Against Cognitive Impairment Caused by Neuro-inflammation and Not in Dementia Due to Ageing Induced by Mitochondrial Dysfunction

    FavorávelEstudo em AnimaisInflamaçãoDisfunção Cognitiva
  19. 2021

    Bioactive Compounds of Arthrospira spp. (Spirulina) with Potential Anticancer Activities: A Systematic Review

    FavorávelMetanáliseCâncerCâncer — CólonFicocianina
  20. 2021

    Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis

  21. 2021

    Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath

    FavorávelEnsaio Clínico Duplo-CegoCanabigerol (CBG)Canabinol (CBN)+2
  22. 2021

    Biomechanical Effects of Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD), the Major Constituents of Cannabis, in a Sprague Dawley Rat Achilles Tendon Surgical Repair Model: A Pilot Study

    InconclusivoEstudo em AnimaisCicatrização
  23. 2021

    Borneol in cardio-cerebrovascular diseases: Pharmacological actions, mechanisms, and therapeutics

    FavorávelMetanáliseDoenças Cardiovasculares (DCV)
  24. 2021

    Borneol inhibits CD4 + T cells proliferation by down-regulating miR-26a and miR-142-3p to attenuate asthma

    FavorávelEstudo em AnimaisInflamaçãoAsma
  25. 2021

    Borneol protects against cerulein-induced oxidative stress and inflammation in acute pancreatitis mice model

    FavorávelEstudo em AnimaisInflamaçãoPancreatite
  26. 2021

    Borneol-modified tanshinone IIA liposome improves cerebral ischemia reperfusion injury by suppressing NF-κB and ICAM-1 expression

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)AVCLesão de Reperfusão
  27. 2021

    Borneol: a Promising Monoterpenoid in Enhancing Drug Delivery Across Various Physiological Barriers

    FavorávelMetanálise
  28. 2021

    Brain imaging of cannabinoid type I (CB1 ) receptors in women with cannabis use disorder and male and female healthy controls

  29. 2021

    Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder

    DesfavorávelMetanáliseAutismo
  30. 2021

    Brugada Electrocardiogram Pattern Induced by Recreational Delta-8-Tetrahydrocannabinol (THC): A Case Report

  31. 2021

    Burden of cannabis use and disorder in the U.S. veteran population: Psychiatric comorbidity, suicidality, and service utilization

    DesfavorávelMetanáliseTentativa de Suicídio
  32. 2021

    Calling for Openness to the Study of Cannabis Use in Chronic Pelvic Pain

    FavorávelMetanáliseDorDor — Crônica
  33. 2021

    Caloric restriction, physical exercise, and CB1 receptor blockade as an efficient combined strategy for bodyweight control and cardiometabolic status improvement in male rats

  34. 2021

    Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?

    FavorávelMetanáliseDorCâncerInflamaçãoCBD Farmacêutico+6
  35. 2021

    Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019

  36. 2021

    Can Eucalyptol Replace Antibiotics?

    FavorávelMetanáliseInfecções Bacterianas
  37. 2021

    Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?

    FavorávelMetanáliseCOVID-19
  38. 2021

    Can Medical Cannabis Therapies be Cost-Effective in the Non-Surgical Management of Chronic Knee Pain?

    FavorávelMetanáliseDorDor — Crônica
  39. 2021

    Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from Cannabis sativa L. Promising Compounds?

    FavorávelMetanáliseCâncerCâncer — MamaCâncer — Cérebro+2
  40. 2021

    Cancer patient's attitudes of using medicinal cannabis for sleep

    FavorávelMetanáliseCâncerInsônia e Distúrbios do Sono
  41. 2021

    Cannabichromene, Related Phytocannabinoids, and 5-Fluoro-cannabichromene Have Anticonvulsant Properties in a Mouse Model of Dravet Syndrome

  42. 2021

    Cannabidiol - A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasObesidadeDoença de Alzheimer+2
  43. 2021

    Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment

    DesfavorávelEstudo LaboratorialInflamaçãoEpilepsiaEstresse Oxidativo
  44. 2021

    Cannabidiol (CBD) and cognition in epilepsy

    FavorávelMetanáliseEpilepsia
  45. 2021

    Cannabidiol (CBD) as a novel treatment in the early phases of psychosis

    FavorávelMetanáliseAnsiedadeDepressãoPsicose+1
  46. 2021

    Cannabidiol (CBD) enhanced the hippocampal immune response and autophagy of APP/PS1 Alzheimer's mice uncovered by RNA-seq

    FavorávelEstudo em AnimaisDoença de Alzheimer
  47. 2021

    Cannabidiol (CBD) For the Treatment of Painful Diabetic Peripheral Neuropathy of the Feet: A Placebo-Controlled, Double-Blind, Randomized Trial

    FavorávelEnsaio Clínico Duplo-CegoDorAnsiedadeDor — Neuropatia Diabética
  48. 2021

    Cannabidiol (CBD) oil toxicity mimicking extraglandular complications of Sjögren’s syndrome

  49. 2021

    Cannabidiol (CBD) Use by Older Adults for Acute and Chronic Pain

    FavorávelMetanáliseDorDor — Crônica
  50. 2021

    Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease

    FavorávelEstudo em AnimaisDisfunção CognitivaDoença de AlzheimerDemência
  51. 2021

    Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase I Clinical Trial

  52. 2021

    Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial

    FavorávelEnsaio Clínico Duplo-CegoPsicoseEsquizofreniaAnandamida (AEA)
  53. 2021

    Cannabidiol and mental health: possibilities, uncertainties, and controversies for addiction treatment

    InconclusivoMetanáliseDependência QuímicaAnsiedadeDepressão+11
  54. 2021

    Cannabidiol and Neurodevelopmental Disorders in Children

  55. 2021

    Cannabidiol and Other Cannabinoids in Demyelinating Diseases

    FavorávelMetanáliseEsclerose MúltiplaAVCTraumatismo Cranioencefálico
  56. 2021

    Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD

    FavorávelEstudo em AnimaisTEPT
  57. 2021

    Cannabidiol and Sodium Channel Pharmacology: General Overview, Mechanism, and Clinical Implications

    FavorávelMetanáliseEpilepsiaEpilepsia — Síndrome de Dravet
  58. 2021

    Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma

    FavorávelMetanáliseGlaucoma
  59. 2021

    Cannabidiol and the corticoraphe circuit in post-traumatic stress disorder

  60. 2021

    Cannabidiol antidepressant-like effect in the lipopolysaccharide model in mice: Modulation of inflammatory pathways

    FavorávelEstudo em AnimaisInflamaçãoDepressão
  61. 2021

    Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research

    FavorávelMetanáliseAnsiedadeDepressão
  62. 2021

    Cannabidiol as a Treatment for Chronic Pain: A Survey of Patients’ Perspectives and Attitudes

    FavorávelEnsaio ClínicoDorDor — Crônica
  63. 2021

    Cannabidiol as a Treatment for Craving and Relapse in Individuals with Cocaine Use Disorder: a Randomized Placebo‐Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaDependência — Cocaína
  64. 2021

    Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic

  65. 2021

    Cannabidiol attenuates cognitive deficits and neuroinflammation induced by early alcohol exposure in a mice model

    FavorávelEstudo em AnimaisDependência QuímicaInflamaçãoDisfunção Cognitiva+3
  66. 2021

    Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice

    FavorávelEstudo em AnimaisDisfunção CognitivaPsicoseEsquizofrenia
  67. 2021

    Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function

    FavorávelEstudo em AnimaisDoenças Cardiovasculares (DCV)Hipertensão Arterial
  68. 2021

    Cannabidiol Cigarettes as Adjunctive Treatment for Psychotic Disorders - A Randomized, Open-Label Pilot-Study

    FavorávelEnsaio Clínico Duplo-CegoPsicose
  69. 2021

    Cannabidiol Confers Neuroprotection in Rats in a Model of Transient Global Cerebral Ischemia: Impact of Hippocampal Synaptic Neuroplasticity

    FavorávelEstudo em AnimaisDisfunção CognitivaAVC
  70. 2021

    Cannabidiol converts NFκB into a tumor suppressor in glioblastoma with defined antioxidative properties

    FavorávelEstudo LaboratorialCâncerCâncer — Cérebro
  71. 2021

    Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13

    FavorávelEstudo LaboratorialInflamaçãoPsicoseEstresse Oxidativo+1
  72. 2021

    Cannabidiol disrupts apoptosis, autophagy and invasion processes of placental trophoblasts

    DesfavorávelEstudo LaboratorialGestaçãoAlterações Cerebrais Neonatais
  73. 2021

    Cannabidiol Does Not Impact Acute Anabolic or Inflammatory Signaling in Skeletal Muscle In Vitro

    InconclusivoEstudo LaboratorialInflamação
  74. 2021

    Cannabidiol Does Not Impair Anabolic Signaling Following Eccentric Contractions in Rats

    FavorávelEstudo em AnimaisInflamação
  75. 2021

    Cannabidiol Effectively Promoted Cell Death in Bladder Cancer and the Improved Intravesical Adhesion Drugs Delivery Strategy Could Be Better Used for Treatment

    FavorávelEstudo LaboratorialCâncer
  76. 2021

    Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors

    FavorávelEstudo em AnimaisDorAnsiedadeDor — Crônica+2
  77. 2021

    Cannabidiol efficiently suppressed the acquisition and expression of methamphetamine-induced conditioned place preference in the rat

  78. 2021

    Cannabidiol enhanced the development of sensitization to the expression of methamphetamine-induced conditioned place preference in male rats

    InconclusivoEstudo em AnimaisDependência QuímicaDependência — CannabisDependência — Cocaína+2
  79. 2021

    Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response

    FavorávelEstudo LaboratorialCâncerCâncer — LeucemiaRejeição de Transplante+1
  80. 2021

    Cannabidiol enhances verbal episodic memory in healthy young participants: A randomized clinical trial

    FavorávelEnsaio Clínico Duplo-CegoEfeitos Adversos da CannabisDisfunção Cognitiva
  81. 2021

    Cannabidiol Exposure During the Mouse Adolescent Period Is Without Harmful Behavioral Effects on Locomotor Activity, Anxiety, and Spatial Memory

    FavorávelEstudo em AnimaisAnsiedadeDisfunção CognitivaAutismo
  82. 2021

    Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

    InconclusivoEnsaio Clínico Duplo-CegoCOVID-19
  83. 2021

    Cannabidiol for Mood Disorders: A Call for More Research

    DesfavorávelMetanáliseDorDor — CrônicaDepressão+4
  84. 2021

    Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder

  85. 2021

    Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaInflamaçãoDependência — CannabisAnandamida (AEA)+9
  86. 2021

    Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain

  87. 2021

    Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice

    FavorávelEstudo em AnimaisTEPT
  88. 2021

    Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats

    FavorávelEstudo em AnimaisDoença de Parkinson
  89. 2021

    Cannabidiol impairs the rewarding effects of methamphetamine: Involvement of dopaminergic receptors in the nucleus accumbens

  90. 2021

    Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials

    FavorávelEnsaio Clínico Duplo-CegoEpilepsiaCBD Farmacêutico
  91. 2021

    Cannabidiol in low back pain: scientific rationale for clinical trials in low back pain

    FavorávelMetanáliseDorDor — CrônicaDor — Aguda
  92. 2021

    Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action

    FavorávelMetanáliseCâncerEpilepsiaDoenças Neurodegenerativas+2
  93. 2021

    Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program

  94. 2021

    Cannabidiol in the management of bruxism in behavioral variant of frontotemporal degeneration

  95. 2021

    Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT 1A and CB 1 receptors

  96. 2021

    Cannabidiol in the Treatment of Epilepsy

  97. 2021

    Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research

    FavorávelMetanáliseEpilepsia
  98. 2021

    Cannabidiol Induces Apoptosis and Perturbs Mitochondrial Function in Human and Canine Glioma Cells

    FavorávelEstudo LaboratorialCâncerCâncer — CérebroAplicações Veterinárias
  99. 2021

    Cannabidiol Induces Autophagy to Protects Neural Cells From Mitochondrial Dysfunction by Upregulating SIRT1 to Inhibits NF-κB and NOTCH Pathways

    FavorávelEstudo LaboratorialDoença de Parkinson
  100. 2021

    Cannabidiol Inhibition of Murine Primary Nociceptors: Tight Binding to Slow Inactivated States of Nav1.8 Channels

    FavorávelEstudo em AnimaisDorDor — AgudaDor — Nociceptiva